ΠΠΎΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΡΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Ρ ΠΠΠ§-1 Ρ ΡΡΠ±ΡΡΡΠ°ΡΠΎΠΌ ΠΈ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠΌ
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΠ΄Π½Π°ΠΊΠΎ ΡΠ½ΠΈΠΊΠ°Π»ΡΠ½ΡΠ΅ ΠΊΡΠΈΡΡΠ°Π»Π»ΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΎΡΠ½ΠΎΡΡΡΡΡ, Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΌ, ΠΊ ΡΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΡΠΊΡΡΡΠ΅, Ρ. Π΅. ΠΊ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΠΈ Π±Π΅Π»ΠΊΠ° ΠΈ ΠΏΠΎΠΊΠ° Π»ΠΈΡΡ Π² ΡΠ΅Π΄ΠΊΠΈΡ ΠΎΡΠΎΠ±ΡΡ ΡΠ»ΡΡΠ°ΡΡ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΠΏΠΎΠ»ΡΡΠΈΡΡ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΡΡΡΠΎΠ΅Π½ΠΈΠΈ Π½Π΅ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΡΡ ΡΠΎΡΡΠΎΡΠ½ΠΈΠΉ (Π½Π°ΠΏΡΠΈΠΌΠ΅Ρ, ΡΠ΅ΡΠΌΠ΅Π½Ρ-ΡΡΠ±ΡΡΡΠ°ΡΠ½ΡΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠΎΠ²). ΠΠΌΠ΅Π½Π½ΠΎ ΠΏΠΎ ΡΡΠΎΠΉ ΠΏΡΠΈΡΠΈΠ½Π΅ Π½Π° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΈ ΡΠΎΠ³ΠΎ ΠΆΠ΅ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° ΠΏΡΠ΅Π΄Π»Π°Π³Π°Π΅ΡΡΡ, ΠΊΠ°ΠΊ ΠΏΡΠ°Π²ΠΈΠ»ΠΎ, Π½Π΅ ΠΎΠ΄Π½Π°, Π° Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΎ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Π.Π. ΠΠΎΠΏΠΎΠ². Π’Π΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅ΡΠΌΠ΅Π½Ρ-ΡΡΠ±ΡΡΡΠ°ΡΠ½ΡΡ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠΉ. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡ. ΠΠΈΠΎΠ»ΠΎΠ³ΠΈΡ 11:5−41 (1977).
- Π.Π. ΠΠΎΠΏΠΎΠ². Π‘ΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ². ΠΠ°ΡΠΊΠ°, Π., 1992).
- Π.Π. ΠΠΎΠΏΠΎΠ². Π‘ΡΡΡΠΊΡΡΡΠ½Π°Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ². ΠΠ°ΡΠΊΠ°, ΠΠΎΡΠΊΠ²Π°, (1989).
- Π.Π. ΠΠΎΠΏΠΎΠ². ΠΠ·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ Π°-Ρ ΠΈΠΌΠΎΡΡΠΈΠΏΡΠΈΠ½Π° Ρ ΡΡΠ±ΡΡΡΠ°ΡΠ°ΠΌΠΈ. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡ. ΠΠΈΠΎΠ»ΠΎΠ³ΠΈΡ 19:1107−1138 (1985).
- Π.Π . ΠΡΠΈΠ³ΠΎΠΆΠΈΠ½. ΠΡ ΡΡΡΠ΅ΡΡΠ²ΡΡΡΠ΅Π³ΠΎ ΠΊ Π²ΠΎΠ·Π½ΠΈΠΊΠ°ΡΡΠ΅ΠΌΡ. ΠΠΈΡ, ΠΠΎΡΠΊΠ²Π°, (1985).
- Π.Π. Π₯ΡΡΠ³ΠΈΠ½, Π. Π‘. Π§Π΅ΡΠ½Π°Π²ΡΠΊΠΈΠΉ, and Π‘. Π. Π¨Π½ΠΎΠ»Ρ. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ. (1967).
- JI.A. ΠΠ»ΡΠΌΠ΅Π½ΡΠ΅Π»ΡΠ΄. ΠΡΠΎΠ±Π»Π΅ΠΌΡ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΠ·ΠΈΠΊΠΈ. ΠΠ°ΡΠΊΠ°, ΠΠΎΡΠΊΠ²Π°, (1974).
- Π. Eyring, R. Lamry, and J. Spikes. Mechanisms of Enzyme Action. Hopkins Univ. Press, Baltimore, (1964).
- D.E.J. Koshland. Molecular basis of enzyme catalysis and control. Pure Appl.Chem. 25 :119−133 (1971).
- D.E.J. Koshland, K.W. Carraway, G.A. Dafforn, D R. Storm. The importance of orientation factors in enzymatic reactions. Cold Spring Harb.Symp.Quant.Biol. 36:13−20(1972).
- Π. ΠΠΆΠ΅Π½ΠΊΡ. ΠΠ°ΡΠ°Π»ΠΈΠ· Π² Ρ ΠΈΠΌΠΈΠΈ ΠΈ ΡΠ½Π·ΠΈΠΌΠΎΠ»ΠΎΠ³ΠΈΠΈ. ΠΠΈΡ, ΠΠΎΡΠΊΠ²Π°, (1972).
- Π.Π. ΠΠΎΠ»ΡΠΊΠ΅Π½ΡΡΠ΅ΠΉΠ½. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π±ΠΈΠΎΡΠΈΠ·ΠΈΠΊΠ°. ΠΠ°ΡΠΊΠ°, ΠΠΎΡΠΊΠ²Π°, (1975).
- A.J. Pertsin and A.I. Kitaigorodsky. The atom-atom potential method: application to organic molecular solids. Springer-Verlag, Berlin, (1987).
- Π.Π.ΠΠΎΠΏΠΎΠ². Π‘ΠΏΠ΅ΡΠΈΡΠΈΠΊΠ° ΠΆΠΈΠ²ΠΎΠ³ΠΎ Π½Π° ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅. ΠΡΠΈΡΠΎΠ΄Π° N6:59−671 993).
- C.M. Ho, G.R. Marshall. FOUNDATION: a program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three- dimensional databases. J Comput.Aided.Mol.Des. 7:3−22 (1993).
- O.F. Guner and L.M. Dumont. 3D searching in computer-aided drug design, in: «Pharmaceutical Manufacturing International». Sterling Publicatons, Cambridge, 65−68 (1990).
- N.W. Murrall, E.K. Davies. Conformational Freedom in 3-D databases. 1.Techinques. J.Chem.Inf.Comput.Sci. 30:316(1990).
- Y.C. Martin. 3D database searching in drug design. J Med.Chem. 35:2145−2154 (1992).
- F.H. Allen, D.G. Watson. The development of versions 3 and 4 of the Cambridge Structural Database system. J.Chem.Inf.Comput.Sci. 31:187−204 (1991).
- R.S. Pearlman. Three dimensional structures: how do we generate them and what can we do with them? Chem.Des.Auto.News 8:3−15 (1993).
- W. Fisanick, K.P. Cross, J.C. Forman, A. Rusinko. Experimental system for similarity and 3D searching of CAS' registry substances. 1.3D substructure searching. J.Chem.Inf.Comput.Sci. 33:548−559(1993).
- P.J. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med.Chem. 28:849−857 (1985).
- A. Miranker, M. Karplus. Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins 11:29−34 (1991).
- G. Lauri, P.A. Bartlett. CAVEAT: a program to facilitate the design of organic molecules. J Comput.Aided.Mol.Des. 8:51−66 (1994).
- MB. Eisen, D.C. Wiley, M. Karplus, R.E. Hubbard. HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 19:199−221 (1994).
- V. Tschinke, N.C. Cohen. The NEWLEADprogram: a new methodfor the design of candidate structures from pharmacophoric hypotheses. J Med.Chem. 36:38 633 870 (1993).
- P.M. Colman. Structure-based drug design. Curr.Opin.Struct.Biol. 4:868−874 (1994).
- R. A. Lewis, A.R. Leach. Current methods for site-directed structure generation. J Comput.Aided.Mol.Des. 8:467−475 (1994).
- H.J. Bohm. LUD1: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput.Aided.Mol.Des. 6:593−606 (1992).
- H.J. Bohm. The computer program LUDI: a new methodfor the de novo design of enzyme inhibitors. J Comput.Aided.Mol.Des. 6:61−78 (1992).
- Y. Nishibata, A. Itai. Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation. Tetrahedron 47:8985−8990(1991).
- S.H. Rotstein, M. A. Murcko. GenStar: a methodfor de novo drug design. J Comput.Aided.Mol.Des. 7:23−43 (1993).
- V.J. Grillet, W. Newell, P. Mata, G. Myatt, S. Sike, Z. Zsoldos, A.P. Johnson. SPROUT: recent developments in the de novo design of molecules. J Chem. Inf Comput. Sei. 34:207−217(1994).
- B.K. Shoichet, I.D. Kuntz. Protein docking and complementarity. J Mol.Biol. 221:327−346 (1991).
- B.K. Shoichet, I.D. Kuntz. Matching chemistry and shape in molecular docking. Protein Eng. 6:723−732 (1993).
- SJ. Weiner, P.A. Kollman, D A. Case, U.C. Singh, C. Ghio, G. Alagona, S.J. Profeta, P. Weiner. A new force-field for molecular mechanical simulation of nucleic acids and proteins. J Amer.Chem.Soc. 106:765−784 (1984).
- S.J. Weiner, P.A. Kollman, D.T. Nguen, D.A. Case. An all-atom force-field for simulation of nucleic acids andproteins. J Comput.Chem. 7:230−252 (1986).
- M.K. Gilson, B. Honig. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins 4:7−18 (1988).
- M.K. Gilson, B.H. Honig. Energetics of charge-charge interactions in proteins published erratum appears in Proteins 1992- 12(2) :201J. Proteins 3:32−52 (1988).
- S.J. Wodak, M. De Crombrugghe, J. Janin. Computer studies of interactions between macromolecules. Prog.Biophys.Mol.Biol. 49:29−63 (1987).
- D. Eisenberg, A.D. McLachlan. Solvation energy in protein folding and binding. Nature 319:199−203 (1986).
- L.M. Gregoret, F.E. Cohen. Novel methodfor the rapid evaluation of packing in protein structures. J Mol.Biol. 211:959−974 (1990).
- J. Ruppert, W. Welch, A.N. Jain. Automatic identification and representation of protein binding sites for molecular docking. Protein Sei. 6:524−533 (1997).
- D.E. Clark, D. Frenkel, S.A. Levy, J. Li, C.W. Murray, B. Robson, B. Waszkowycz, D.R. Westhead. PRO-LIGAND: an approach to de novo moleculardesign. 1. Application to the design of organic molecules. J Comput.Aided.Mol.Des. 9:13−32 (1995).
- M. Rarey, B. Kramer, T. Lengauer. Time-efficient docking of flexible ligands into active sites of proteins. Ismb. 3:300−308 (1995).
- M.D. Miller, S.K. Kearsley, D.J. Underwood, R.P. Sheridan. FLOG: a system to select 'quasi-flexible' ligands complementary to a receptor of known three-dimensional structure. J Comput.Aided.Mol.Des. 8:153−174 (1994).
- W. Welch, J. Ruppert, A.N. Jain. Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites. Chem.Biol. 3:449−462 (1996).
- I.D. Kuntz, J.M. Blaney, S.J. Oatley, R. Langridge, T.E. Ferrin. A geometric approach to macromolecule-ligand interactions. J Mol.Biol. 161:269−288 (1982).
- I.D. Kuntz. Structure-based strategies for drug design and discovery see comments. Science 257:1078−1082 (1992).
- J.M. Blaney, J.S. Dixon. A good ligand is hard to find: automated docking methods. Perspect.Drug.Disc.Design 1:301−319 (1993).
- I.D. Kuntz, E.C. Meng, B.K. Shoichet. Structure-based molecular design. Acc.Chem.Res. 27:117−123 (1994).
- D.S. Goodsell, A.J. Olson. Automated docking of substrates to proteins by simulated annealing. Proteins 8:195−202 (1990).
- S.Y. Yue. Distance-constrained molecular docking by simulated annealing. Protein Eng. 4:177−184 (1990).
- T.N. Hart, R.J. Read. A multiple-start Monte Carlo docking method. Proteins 13:206−222 (1992).
- A. Caflisch, P. Niederer, M. Anliker. Monte Carlo docking of oligopeptides to proteins. Proteins 13:223−230 (1992).
- D.S. Goodsell, H. Lauble, C.D. Stout, A.J. Olson. Automated docking in crystallography: analysis of the substrates of aconitase. Proteins 17:1−10 (1993).
- R.M. Knegtel, J. Antoon, C. Rullmann, R. Boelens, R. Kaptein. MONTY: a Monte Carlo approach toprotein-DNA recognition. J Mol.Biol. 235:318−324 (1994).
- M.K. Gilson, T.P. Straatsma, J.A. McCammon, D R. Ripoll, C.H. Faerman, P.H. Axelsen, I. Silman, J.L. Sussman. Open «back door» in a molecular dynamics simulation of acetylcholinesterase. Science 263:1276−1278 (1994).
- B.A. Luty, Z.R. Wasserman, P.F.W. Stouten, C.N. odge, M. Zacharias, J.A. McCammon. A molecidar mechanics/grid method for evaluation of lygand-receptor interactions. J Comput.Chem. 16:454−464(1995).
- A. Di Nola, D. Roccatano, H. J. Berendsen. Molecular dynamics simulation of the docking of substrates to proteins. Proteins 19:174−182(1994).
- J. Cherfils, J. Janin. Protein docking algorithms: sumulating molecular recognition. Curr.Opin.Struct.Biol. 3:265−269(1993).
- D.K. Gehlhaar, G.M. Verkhivker, P.A. Rejto, C.J. Sherman, D.B. Fogel, L.J. Fogel, S.T. Freer. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformational flexible docking by evolutionary programming. C.hem.Biol. 2:317−324 (1995).
- D.B. Fogel. Evolutionary Computation: Forward a New Philosophy of Machine Intelligence. IEEE Press, Piscataway, (1995).
- L.J. Fogel, A. J. Owens, and M.J. Walsh. Artificial Intelligence Through Simulated Evolution. Wiley, New York, (1996).
- P.H. Winston. «Artificial Intelligence. 3rd edition.». Addison-Wesley Publ., Reading, MA, 63−100(1992).
- J.B. Moon, W J. Howe. Computer design of bioactive molecules: a methodfor receptor-based de novo ligand design. Proteins 11:314−328 (1991).
- W. Hasel, T.F. Hendrickson, W.C. Still. A rapid approximation to the solvent accessible surface area of atoms. Tetrahedron 1:103−116 (1988).
- K. Suguna, E.A. Padlan, C.W. Smith, W.D. Carlson, D.R. Davies. Binding of a reduced peptide inhibitor to the aspartic proteinase from Khizopus chinensis: implications for a mechanism of action. Proc.Natl.Acad.Sci.U.S.A. 84:7009−7013 (1987).
- M. Miller, J. Schneider, B.K. Sathyanarayana, M.V. Toth, G.R. Marshall, L. Clawson, L. Selk, S.B. Kent, A. Wlodawer. Structure of complex of synthetic H1V-1 protease with a substrate-based inhibitor at 2.3 A resolution. Science 246:1149−1152 (1989).
- M. Rarey, B. Kramer, T. Lengauer, G. Klebe. A fast flexible docking method using an incremental construction algorithm. J Mol.Biol. 261:470−489 (1996).
- G. Klebe, T. Mietzner. A fast and efficient method to generate biologically relevant conformations. J Comput.Aided.Mol.Des. 8:583−606 (1994).
- P.J. DeClerq. Systematic Conformational Analysis. A microcomputer methodfor the semi-quantitative evaluation ofpolycyclic containing five-six- andseven-memberedrings: Program Characteristics. Tetrahedron 40:3717−3727 (1984).
- M. Rarey, S. Wefing, T. Lengauer. Placement of medium-sized molecular fragments into active sites of proteins. J Comput. Aided.Mol.Des. 10:41−54 (1996).
- D. Fischer, S.L. Lin, H.L. Wolfson, R. Nussinov. A geometry-based suite of molecular docking processes. J Mol.Biol. 248:459−477 (1995).
- H.J. Bohm. On the use ofLUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure. J
- Comput. Aided.Mol.Des. 8:623−632 (1994).
- D.W. Banner, P. Hadvary. Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. J Biol.Chem. 266:20 085−20 093 (1991).
- A.R. Leach. Ligand docking to proteins with discrete side-chain flexibility. J Mol.Biol. 235:345−356 (1994).
- T.L. Blundell, B.L. Sibanda, M. Sternberg, J.M. Thornton. Knowledge-based prediction of protein structure and the design of novel molecules. Nature 326:347−352 (1987).
- R.E. Bruccoleri, M. Karplus. Chain closure with bond-angle variations. Macromolecules 18:2767−2773 (1985).
- R.E. Bruccoleri, M. Karplus. Prediction of the folding of short polypeptide segments by uniform conformational sampling. Biopolymers 26:137−168 (1987).
- L. Holm, C. Sander. Fast and simple Monte Carlo algorithm for side chain optimization in proteins: application to model building by homology. Proteins 14:213−223 (1992).
- C. Lee, S. Subbiah. Prediction of protein side-chain conformation by packing optimization. J Mol.Biol. 217:373−388 (1991).
- P. Tuffery, C. Etchebest, S. Hazout, R. Lavery. A new approach to the rapid determination of protein side chain conformations. J Biomol.Struct.Dyn. 8:12 671 289 (1991).
- J. Desmet, M. DeMaeyer, B. Hazes, I. Lasters. The dead-end elimination theorem and its use in protein side-chain positioning. Nature 356:539−542 (1992).
- P.E. Hart, N.J. Nilsson, B. Raphael. A formal bases for the heuristic detemination of minimum caused path. JEEE Trans on SSC 4:100−114 (1968).
- N.J. Nilsson. «Principles of Artificial Intelligence». Springer-Verlag, Berlin, 7488 (1982).
- A.R. Leach, I.D. Kuntz. Conformational analysis of flexible ligands of macromolecular receptor cites. J Comput.Chem. 13:730−748 (1992).
- U.C. Singh, P.A. Kollman. UCSF Gaussian-80.QCPE bulletin 2. 17 (program 446)(1982).
- J.W. Ponder, F.M. Richards. Tertiary templates for proteins. Use ofpacking criteria in the enumeration of allowed sequences for different structural classes. J Mol.Biol. 193:775−791 (1987).
- A. Tropsha, J. Hermans. Application offree energy simulations to the binding of a transition- state-analogue inhibitor to HIV protease. Protein Eng. 5:29−33 (1992).
- C.E. Sansom, J. Wu, IT. Weber. Molecular mechanics analysis of inhibitor binding to HIV-I protease. Protein Eng. 5:659−667 (1992).
- I.T. Weber, R.W. Harrison. Molecular mechanics calculations on HIV-I protease with peptide substrates correlate with experimental data. Protein Eng. 9:679−690 (1996).
- T.J.A. Ewing, T.P. Lybrand. J Phys. Chem 98:1748−1752 (1994).
- C.S. Ring, E. Sun, J.H. McKerrow, G.K. Lee, P.J. Rosenthal, ID. Kuntz, F.E. Cohen. Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc.Natl.Acad.Sci.U.S.A. 90:3583−3587 (1993).
- D.L. Bodian, R.B. Yamasaki, R.L. Buswell, J.F. Stearns, J.M. White, ID. Kuntz. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32:2967−2978 (1993).
- P.Y. Lam, P.K. Jadhav, C.J. Eyermann, C.N. Hodge, Y. Ru, L.T. Bacheler, J.L. Meek, M.J. Otto, M.M. Rayner, Y.N. Wong. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science 263:380−384 (1994).
- M. von Itzstein, W.Y. Wu, G.B. Kok, M.S. Pegg, J.C. Dyason, B. Jin, T. Van Phan, M.L. Smythe, H.F. White, S.W. Oliver. Rational design of potent sialidase-based inhibitors of influenza virus replication see comments. Nature 363:418 423 (1993).
- H. Nakanishi, R.A. Chrusciel, R. Shen, S. Bertenshaw, M.E. Johnson, T.J. Rydel, A. Tulinsky, M. Kahn. Peptide mimetics of the thrombin-bound structure of fibrinopeptideA. Proc.Natl.Acad.Sci.U.S.A. 89:1705−1709(1992).
- K. Padmanabhan, K.P. Padmanabhan, J.D. Ferrara, J.E. Sadler, A. Tulinsky. The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J Biol.Chem. 268:17 651−17 654 (1993).
- B.K. Shoichet, R.M. Stroud, D.V. Santi, I.D. Kuntz, K.M. Perry. Structure-based discovery of inhibitors of thymidylate synthase. Science 259:1445−1450 (1993).
- C. Mattos, B. Rasmussen, X. Ding, G.A. Petsko, D. Ringe. Analogous inhibitors of elastase do not always bind analogously. Nat.Struct.Biol. 1:55−58 (1994).
- D. Ringe. Immunosuppression. Binding by design news- comment. Nature 351:185−186 (1991).
- R.H. Hoess. Curr.Opin.StruCt.Biol. 3:572−579 (1993).
- A.N. Jain. Scoring noncovalent protein-ligand interactions: a continuous dijferentiable function tuned to compute binding affinities. J Comput.Aided.Mol.Des. 10:427−440 (1996).
- S.L. Lin, R. Nussinov, D. Fischer, H.J. Wolfson. Molecular surface representations by sparse critical points. Proteins 18:94−101 (1994).
- R. Norel, D. Fischer, H.J. Wolfson, R. Nussinov. Molecular surface recognition by a computer vision-based technique. Protein Eng. 7:39−46 (1994).
- M. Helmer-Citterich, A. Tramontano. PUZZLE: a new methodfor automated protein docking based on surface shape complementarity. J Mol.Biol. 235:1021 -1031 (1994).
- Y.L. Xiao, D.E. Williams. Genetic algotithmsfor docking of actinomicine D and the d-oxyguanosine molecules. J Phys. Chem 98:7191(1994).
- R.S. Judson, Y.T. Tan, E. Mori. J Comput.Chem. 11:1405−1419 (1995).
- C.M. Oshiro, I.D. Kuntz, J.S. Dixon. Flexible ligand docking using a genetic algorithm. J Comput.Aided.Mol.Des. 9:113−130(1995).
- T. Dandekar, P. Argos. Folding the main chain of small proteins with the genetic algorithm. J Mol.Biol. 236:844−861 (1994).
- G. Jones, P. Willett, R.C. Glen. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J Mol.Biol. 245:43−53 (1995).
- J.H. Holland. Adaptation in natural and artificial systems. MIT Press, Cambridge, MA, (1992).
- D.E. Goldberg. Genetic algorithms in search, optimization and machine learning. Addison-Wesley, Reading MA, (1989).
- D.E. Goldberg. Complex Syst. 5:139−150 (1991).
- Handbook of Genetic Algorithms. Van Nostrand Reinhold, New York, (1991).
- L.D. Whitley. Foundations of Genetic Algorithms. Morgan Kaufmann, Los Altos, CA, (1993).
- L.B. Booker. Mach.Learn. 9:29−44 (1991).
- A. Bergman, M.W. Feldman. Physica D56.57−68 (1992).
- G.E. Liepins, M.D. Vose. J Exp.Theor.Artif.Intel. 2:101−108 (1990).
- D.E. Goldberg, K. Deb, J.H. Clark. Complex Syst. 6:(1992).
- J.P. Ros. «Foundation of genetic algorithms». Morgan Kaufmann, Los Altos, CA., 257−276 (1993).
- S. Forrest. Genetic algorithms: principles of natural selection applied to computation. Science 261:872−878 (1993).
- N.S. Andreeva, A.E. Gustchina, A.A. Fedorov, N.E. Shutzkever, T.V. Volnova. X-ray crystallographic studies of pepsin. Adv. Exp Med.Biol. 95:23−31 (1977).
- C. Abad-Zapatero, T.J. Rydel, J. Erickson. Revised 2.3 A structure of porcine pepsin: evidence for a flexible subdomain. Proteins 8:62−81 (1990).
- A.R. Sielecki, A.A. Fedorov, A. Boodhoo, N.S. Andreeva, M.N. James. Molecular and crystal structures of monoclinic porcine pepsin refined at 1.8 A resolution. J Mol.Biol. 214:143−170 (1990).
- J.B. Cooper, G. Khan, G. Taylor, I.J. Tickle, T.L. Blundell. X-ray analyses of aspartic proteinases. II. Three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 A resolution. J Mol.Biol. 214:199−222 (1990).
- A.R. Sielecki, M. Fujinaga, R.J. Read, M.N. James. Refined structure of porcine pepsinogen at 1.8 A resolution. J Mol.Biol. 219:671−692 (1991).
- J. A. Hartsuck, G. Koelsch, S.J. Remington. The high-resolution crystal structure of porcine pepsinogen. Proteins 13:1−25 (1992).
- G.L. Gilliland, E.L. Winborne, J. Nachman, A. Wlodawer. The three-dimensional structure of recombinant bovine chymosin at 2.3 A resolution. Proteins 8:82−101 (1990).
- M. Newman, M. Safro, C. Frazao, G. Khan, A. Zdanov, I.J. Tickle, T.L. Blundell, N. Andreeva. X-ray analyses of aspartic proteinases. IV. Structure and refinement at 2.2 A resolution of bovine chymosin. J Mol.Biol. 221:1295−1309 (1991).
- I.N. Hsu, L.T. Delbaere, M.N. James, T. Hofmann. Penicillopepsin from Penicillium janthinellum crystal structure at 2.8 A and sequence homology with porcine pepsin. Nature 266:140−145 (1977).
- M.N. James, A.R. Sielecki. Structure and refinement ofpenicillopepsin at 1.8 A resolution. J Mol.Biol. 163:299−361 (1983).
- C. Wong, T.J. Lee, T. Y. Lee, T.H. Lu, C.S. Hung. The structure of acid protease from Endothia parasitica in cross-linked form at 3.5 A resolution. Biochem.Biophys.Res.Commun. 80:891−896 (1978).
- L. Pearl, T. Blundell. The active site of aspartic proteinases. FEBS Lett. 174:96 101 (1984).
- E. Subramanian, M. Liu, I.D. Swan, D.R. Davies. The crystal structure of an acid protease from Rhizopus chinensis at 2.5 A resolution. Adv. Exp Med.Biol. 95:3341 (1977).
- K. Suguna, R.R. Bott, E.A. Padlan, E. Subramanian, S. Sheriff, G.H. Cohen, D.R. Davies. Structure and refinement at 1.8 A resolution of the aspartic proteinase from Rhizopus chinensis. J Mol.Biol. 196:877−900 (1987).
- A.R. Khan, M.M. Cherney, N.I. Tarasova, M.N. James. Structural characterization of activation 'intermediate 2' on the pathway to human gastricsin. Nat.Struct.Biol. 4:1010−1015 (1997).
- S.A. Moore, A.R. Sielecki, M.M. Chernaia, N.I. Tarasova, M.N. James. Crystal and molecular structures of human progastricsin at 1.62 A resolution. J Mol.Biol. 247 :466−485 (1995).
- J. Yang, A. Teplyakov, J.W. Quail. Crystal structure of the aspartic proteinase from Rhizomucor miehei at 2.15 A resolution. J Mol.Biol. 268:449−459 (1997).
- M.A. Navia, P.M. Fitzgerald, B.M. McKeever, C.T. Leu, J.C. Heimbach, W.K. Herber, I.S. Sigal, P.L. Darke, J.P. Springer. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337:615 620 (1989).
- S. Spinelli, Q.Z. Liu, P.M. Alzari, P.H. Hirel, R.J. Poljak. The three-dimensional structure of the aspartyl protease from the HIV-1 isolate BRIJ. Biochimie 73:1391−1396(1991).
- A. Wlodawer, M. Miller, M. Jaskolski, B.K. Sathyanarayana, E. Baldwin, IT. Weber, L.M. Selk, L. Clawson, J. Schneider, S.B. Kent. Conservedfolding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science 245:616−621 (1989).
- D.H. Ohlendorf, S.I. Foundling, J.J. Wendoloski, J. Sedlacek, P. Strop, F.R. Salemme. Structural studies of the retroviral proteinase from avian myeloblastosis associated virus. Proteins 14:382−391 (1992).
- M. Jaskolski, M. Miller, J.K. Rao, J. Leis, A. Wlodawer. Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2-A resolution. Biochemistry 29:5889−5898 (1990).
- R.B. Rose, C.S. Craik, R.M. Stroud. Domainflexibility in retroviral proteases: structural implications for drug resistant mutations. Biochemistry 37:2607−2621 (1998).
- A.F. Wilderspin, R.J. Sugrue. Alternative native flap conformation revealed by 2.3 A resolution structure of SIVproteinase. J Mol.Biol. 239:97−103 (1994).
- M. Fujinaga, M.M. Chernaia, N.I. Tarasova, S.C. Mosimann, M.N. James. Crystal structure of human pepsin and its complex with pepstatin. Protein Sci. 4:960−972 (1995).
- M.E. Fraser, N.C. Strynadka, P.A. Bartlett, J.E. Hanson, M.N. James. Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues. Biochemistry 31:5201−5214 (1992).
- M.N. James, A.R. Sielecki, K. Hayakawa, M.H. Gelb. Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containingpeptides. Biochemistry 31:3872−3886 (1992).
- K. Suguna, E.A. Padlan, R. Bott, J. Boger, K.D. Parris, D.R. Davies. Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors. Proteins 13:195−205 (1992).
- J. Cooper, W. Quail, C. Frazao, S.I. Foundling, T.L. Blundell, C. Humblet, E.A. Lunney, W.T. Lowther, B.M. Dunn. X-ray crystallographic analysis of inhibition of endothiapepsin by cyclohexyl renin inhibitors. Biochemistry 31:8142−81 501 992).
- T.L. Blundell, J.A. Jenkins, B.T. Sewell, L.H. Pearl, J.B. Cooper, I.J. Tickle, B. Veerapandian, S.P. Wood. X-ray analyses of asparticproteinases. The three-dimensional structure at 2.1 A resolution of endothiapepsin. J Mol.Biol. 211:919 941 (1990).
- D. Bailey J.B. Cooper. A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica. Protein Sci. 3:2129−2143 (1994).
- J.B. Cooper, S.I. Foundling, T.L. Blundell, J. Boger, R.A. Jupp, J. Kay. X-ray studies of aspartic proteinase-statine inhibitor complexes. Biochemistry 28:85 968 603 (1989).
- S.I. Foundling, J. Cooper, F.E. Watson, A. Cleasby, L.H. Pearl, B.L. Sibanda, A. Hemmings, S.P. Wood, T.L. Blundell, M.J. Valler. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes. Nature 327:349−352 (1987).
- S.M. Cutfield, E.J. Dodson, B.F. Anderson, P.C. Moody, C.J. Marshall, P.A. Sullivan, J.F. Cutfield. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure. 3:1261−1271 (1995).
- J.M. Louis, F. Dyda, N.T. Nashed, A.R. Kimmel, D R. Davies. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease. Biochemistry 37:2105−2110 (1998).
- K. Backbro, S. Lowgren, K. Osterlund, J. Atepo, T. Unge, Hulten, N.M. Bonham, W. Schaal, A. Karlen, A. Hallberg. Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor. J Med. Chem 40:898−902 (1997).
- L. Hong, J.A. Hartsuck, S. Foundling, J. Ermolieff, J. Tang. Active-site mobility in human immunodeficiency virus, type 1, protease as demonstrated by crystal structure of A28Smutant. Protein Sci. 7:300−305 (1998).
- A.M. Silva, R.E. Cachau, H.L. Sham, J.W. Erickson. Inhibition and catalytic mechanism of HIV-1 aspartic protease. J Mol.Biol. 255:321−346 (1996).
- R. Bone, J.P. Vacca, P. S. Anderson, M.K. Holloway. X-ray crystal structure of the HIV protease complex with L-700,417, an inhibitor with pseudo C2 symmetry. J Amer.Chem.Soc. 113:9382−9387 (1991).
- A.L. Swain, M.M. Miller, J. Green, D.H. Rich, J. Schneider, A. Wlodawer. X-ray crystallographic structure of a complex between a synthetic protease of HIV-1 and a substrate-based hydroxyethylamine inhibitor. Proc.Natl.Acad.Sci.U.S.A. 87:8809(1990).
- L. Pearl, W. Taylor. Nature 329:351−354 (1987).
- C.L. Dilanni, L.J. Davis, M.K. Holloway, W.K. Herber, P.L. Darke, N.E. Kohl, R. A. Dixon. Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease. J Biol. Chem 265:17 348−17 354 (1990).
- A.G. Tomasselli, W.J. Howe, T.K. Sawyer. Comp.Phys.Commun. N5:6−27 (1991).
- S.P. Jordan, J. Zugay, P.L. Darke, L.C. Kuo. Activity and dimerization of human immunodeficiency virus protease as a function of solvent composition and enzyme concentration. J Biol. Chem 267:20 028−20 032 (1992).
- S. Seelmeier, H. Schmidt, V. Turk, H. von der. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proc.Natl.Acad.Sci.U.S.A. 85:6612−6616 (1988).
- N.E. Kohl, E.A. Emini, W.A. Schleif, L.J. Davis, J.C. Heimbach, R. A, Dixon, E.M. Scolnick, I.S. Sigal. Active human immunodeficiency virus protease is required for viral infectivity. Proc.Natl.Acad.Sci.U.S.A. 85:4686−4690 (1988).
- S.F. Le Grice, J. Mills, J. Mous. Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation, EMBO J 7:2547−25 531 988).
- D.D. Loeb, R. Swanstrom, L. Everitt, M. Manchester, S.E. Stamper, C.A. Hutchison. Complete mutagenesis of the HIV-1 protease. Nature 340:397−4 001 989).
- X.L. Lin, R.N. Wong, J. Tang. Synthesis, purification, and active site mutagenesis of recombinant porcine pepsinogen. J Biol. Chem 264:4482−4489 (1989).
- L.M. Babe, S. Pichuantes, C.S. Craik. Inhibition of HIV protease activity by heterodimer formation. Biochemistry 30:106−111 (1991).
- H.J. Schramm, A. Billich, E. Jaeger, K.P. Rucknagel, G. Arnold, W. Schramm. The inhibition of HIV-1 protease by interface peptides. Biochem.Biophys.Res.Commun. 194:595−600 (1993).
- J. Hajdu, K.R. Acharya, D.I. Stuart, P.J. McLaughlin, D. Barford, N.G. Oikonomakos, H. Klein, L.N. Johnson. Catalysis in the crystal: synchrotron radiation studies with glycogenphosphorylase b. EMBO J 6:539−546 (1987).
- L.N. Johnson, S.H. Hu, D. Barford. Catalytic mechanism of glycogen phosphorylase. Faraday.Discuss. 131−142(1992).
- E D. Lowe, M.E. Noble, V.T. Skamnaki, N.G. Oikonomakos, D.J. Owen, L.N. Johnson. The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition. EMBO J 16:6646−6658 (1997).
- K.H. Verschueren, F. Seljee, H.J. Rozeboom, K.H. Kalk, B.W. Dijkstra. Crystallographic analysis of the catalytic mechanism of haloalkane dehalogenase see comments. Nature 363:693−698 (1993).
- H. Π‘. ΠΠ½Π΄ΡΠ΅Π΅Π²Π°, Π£ΡΡΠ½ΠΎΠ΅ ΡΠΎΠΎΠ±ΡΠ΅Π½ΠΈΠ΅
- W.A. Hendrickson. Stereochemical restrained refinement of macromolecular structures. Methods Enzymol. 115:252−270(1985).
- B.C. Finzel. J Appl.Crystallogr. 20:53−55 (1987).
- A. Brunger. A system for X-ray crystallography and NMR, in: «X-PLOR version 3.1». Yale University Press, New Haven, CT, (1995).
- T.A. Jones. Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. Methods Enzymol. 115:157−171 (1985).
- R. Smith, I.M. Brereton, R.Y. Chai, S.B. Kent. Ionization states of the catalytic residues in HIV-1 protease. Nat.Struct.Biol. 3:946−950 (1996).
- IIJPAC-IUB Commission on Biochemical Nomenclature. Biochem.Biophys.Acta. 19:1−17(1971).
- M.E. ΠΠΎΠΏΠΎΠ², Π. Π. ΠΠ°ΡΠΏΠ°ΡΠΎΠ², E.M. ΠΠΎΠΏΠΎΠ². ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ Π°ΡΠΏΠ°ΡΡΠ°ΡΠ½ΡΡ ΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·. II ΠΠΎΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΡΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π³Π΅ΠΏΡΠ°ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΠΎΠ³ΠΎ ΡΡΠ±ΡΡΡΠ°ΡΠ° ΠΏΡΠΎΡΠ΅ΠΈΠ½Π°Π·Ρ HIV-L ΠΠΈΠΎΠΎΡΠ³Π°Π½. Π₯ΠΈΠΌΠΈΡ 22:510−522 (1996).
- A.M. Silva, R.E. Cachau, H.L. Sham, J.W. Erickson. Inhibition and catalytic mechanism of HIV-1 aspartic protease. J.Mol.Biol. 255:321−346 (1996).
- E.M. Popov. Quantitative approach to conformations of proteins. Int.J.Quant.Chem. 16:707−737(1979).
- E.M. ΠΠΎΠΏΠΎΠ², Π. Π. ΠΠΈΠΏΠΊΠΈΠ½Π΄, Π‘. Π€. ΠΡΡ ΠΈΠΏΠΎΠ²Π°. Π’Π΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΉ ΠΌΠ΅ΡΠΈΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄Π½ΡΡ Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡ. ΠΠ·Π². ΠΠ Π‘Π‘Π‘Π .Π‘Π΅Ρ.Ρ ΠΈΠΌ. N2:312−319 (1971).
- Y. Kong, J.W. Ponder. J.Chem.Phys. 107:481−492(1997).
- M.J. Dudek, J. W. Ponder. Accurate Modeling of the Intramolecular Electrostatic Energy of Proteins. J. Comput.Chem. 16:791−816 (1995).
- Π.Π. ΠΠ°ΡΠΏΠ°ΡΠΎΠ², M.E. ΠΠΎΠΏΠΎΠ², Π. Π. Π ΡΠΌΡ, E.M. ΠΠΎΠΏΠΎΠ². Π ΠΈΠ·ΠΎΠΏΡΡΠΏΠ΅ΠΏΡΠΈΠ½ — Π½Π΅Π²Π°Π»Π΅Π½ΡΠ½ΡΠ΅ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΡ. ΠΠΈΠΎΠΎΡΠ³Π°Π½. Π₯ΠΈΠΌΠΈΡ (1999).
- Π.Π. ΠΠ½ΡΠΎΠ½ΠΎΠ². Π₯ΠΈΠΌΠΈΡ ΠΏΡΠΎΡΠ΅ΠΎΠ»ΠΈΠ·Π°. ΠΠ°ΡΠΊΠ°, ΠΠΎΡΠΊΠ²Π°, (1991).
- L.H. Pearl. The catalytic mechanism of aspartic proteinases. FEBS Lett. 214:8−12 (1987).
- N.I. Dergousova, Yu.F. Leonova, A.A. Zinchenko, L.D. Rumsh, N.S. Andreeva. Mutant of HIV-1 Protease with New Specific properties. Protein and Peptide Letters 4:321−328 (1997).